Pembrolizumab + MRGOO3 as Neoadjuvant in NPC
Clinical trial NCT07267338 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07267338
- Sponsor
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-01
- Primary completion
- 2027-12-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.